These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 377449)

  • 1. Clinical comparative evaluation of choline magnesium trisalicylate and acetylsalicylic acid in rheumatoid arthritis.
    Blechman WJ; Lechner BL
    Rheumatol Rehabil; 1979 May; 18(2):119-24. PubMed ID: 377449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of a non-acetylated salicylate, choline magnesium trisalicylate, in the treatment of rheumatoid arthritis.
    Rothwell KG
    J Int Med Res; 1983; 11(6):343-8. PubMed ID: 6360749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of choline magnesium trisalicylate and acetylsalicylic acid in patients with rheumatoid arthritis.
    Le Gallez P; Bird HA; Wright V
    Curr Med Res Opin; 1990; 12(2):71-5. PubMed ID: 2202551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choline magnesium trisalicylate versus ibuprofen in rheumatoid arthritis.
    Ehrlich GE; Miller SB; Zeiders RS
    Rheumatol Rehabil; 1980 Feb; 19(1):30-41. PubMed ID: 7361026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily treatment of rheumatoid arthritis with choline magnesium trisalicylate.
    Mann CC; Boyer JT
    Clin Ther; 1984; 6(2):170-7. PubMed ID: 6705011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparable serum salicylate concentrations from choline magnesium trisalicylate, aspirin, and buffered aspirin in rheumatoid arthritis.
    Binus MH; Lyon JA; Nicholas JL
    Arthritis Rheum; 1982 Apr; 25(4):464-6. PubMed ID: 7073776
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical evaluation of choline magnesium trisalicylate in rheumatoid arthritis.
    Mody GM; Naidoo PD; Singh TG
    S Afr Med J; 1983 Aug; 64(6):195-6. PubMed ID: 6348967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled study of concurrent therapy with a nonacetylated salicylate and naproxen in rheumatoid arthritis.
    Furst DE; Blocka K; Cassell S; Harris ER; Hirschberg JM; Josephson N; Lachenbruch PA; Trimble RB; Paulus HE
    Arthritis Rheum; 1987 Feb; 30(2):146-54. PubMed ID: 3548732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of choline magnesium trisalicylate (CMT) in the management of metastatic bone pain: a pilot study.
    Johnson JR; Miller AJ
    Palliat Med; 1994; 8(2):129-35. PubMed ID: 7521713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic evaluation of the comparative effects of acetylsalicylic acid and choline magnesium trisalicylate on human gastric and duodenal mucosa.
    Kilander A; Dotevall G
    Br J Rheumatol; 1983 Feb; 22(1):36-40. PubMed ID: 6337663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choline magnesium trisalicylate in patients with aspirin-induced asthma.
    Szczeklik A; Nizankowska E; Dworski R
    Eur Respir J; 1990 May; 3(5):535-9. PubMed ID: 2198165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled trial of magnesium dithiosalicylate compared with aspirin in rheumatoid arthritis.
    Dequeker J; Stevens E; Wuyts L
    Curr Med Res Opin; 1980; 6(9):589-92. PubMed ID: 6996929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of choline magnesium trisalicylate as an alternative to aspirin for patients with bleeding tendencies.
    Danesh BJ; Saniabadi AR; Russell RI; Lowe GD
    Scott Med J; 1987 Dec; 32(6):167-8. PubMed ID: 3329766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the non-steroidal anti-inflammatory drug choline magnesium trisalicylate on gastric mucosal cell exfoliation.
    Mitchell KG; Hearns J; Crean GP
    Br J Clin Pharmacol; 1984 Jan; 17(1):27-30. PubMed ID: 6691886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis.
    Tracy TS; Krohn K; Jones DR; Bradley JD; Hall SD; Brater DC
    Eur J Clin Pharmacol; 1992; 42(2):121-5. PubMed ID: 1618240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative, double-blind study on tolfenamic acid in the treatment of rheumatoid arthritis.
    Rejholec V; Vapaatalo H; Tokola O; Gothoni G
    Scand J Rheumatol Suppl; 1979; (24):13-6. PubMed ID: 373084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choline magnesium trisalicylate--a new formulation of salicylate.
    Klemp P; Meyers OL
    S Afr Med J; 1982 Dec; 62(25):927-8. PubMed ID: 7147131
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind comparison of aspirin and 4-(acetamido) phenyl-2-acetoxy-benzoate (benorylate) in rheumatoid arthritis.
    Sperryn PN; Hamilton EB; Parsons V
    Ann Rheum Dis; 1973 Mar; 32(2):157-61. PubMed ID: 4571392
    [No Abstract]   [Full Text] [Related]  

  • 19. A pharmacokinetic comparison of choline magnesium trisalicylate and soluble aspirin.
    Helliwell M; Gibson T; Berry D; Volans G
    Br J Rheumatol; 1984 Nov; 23(4):288-91. PubMed ID: 6487934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diflunisal 500-750 mg versus aspirin 2600-3900 mg in the treatment of rheumatoid arthritis.
    Turner RA; Whipple JP; Shackleford RW
    Pharmacotherapy; 1984; 4(3):151-7. PubMed ID: 6377249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.